New CPA–Responsible Battery Coalition Report Warns China’s Dominance of Battery Processing is a Threat to U.S. National Security

New CPA–Responsible Battery Coalition Report Warns China’s Dominance of Battery Processing is a Threat to U.S. National Security

The report finds that China has consolidated global dominance in the midstream stages of battery supply chains—refining and chemical conversion—giving the Chinese Communist Party significant influence over pricing, supply availability, and industrial investment.

CPA Applauds Bipartisan Senate Banking Committee Letter Urging SEC to Crack Down on China’s Exploitation of U.S. Capital Markets

CPA Applauds Bipartisan Senate Banking Committee Letter Urging SEC to Crack Down on China’s Exploitation of U.S. Capital Markets

This bipartisan letter from the Senate Banking Committee is a powerful signal that Congress is finally taking seriously what CPA has been warning about for years: the Chinese Communist Party has been exploiting America’s capital markets to fund its military modernization, underwrite its surveillance state, and enrich entities engaged in genocide, forced labor, and espionage — all with American investor capital.

CPA Applauds Bipartisan Senate Letter Supporting Section 232 Polysilicon Investigation

CPA Applauds Bipartisan Senate Letter Supporting Section 232 Polysilicon Investigation

The letter underscores a critical point: any effective policy response must address the entire solar supply chain—from polysilicon to ingots, wafers, cells, and finished modules—rather than focusing on a single segment in isolation.

Sen. Gillibrand Says U.S. Generics Need Incentives to Reshore; Cost Shouldn’t Trump Quality

Sen. Gillibrand Says U.S. Generics Need Incentives to Reshore; Cost Shouldn’t Trump Quality

It’s the second month in a row now that the U.S. Senate Special Committee on Aging has taken up the question of our woeful generics supply chain. This time, however, Ranking Member Kirsten Gillibrand (D-NY), started the hearing off by touching on a key topic in pharmaceuticals: the cost equation can no longer override the quality equation.

CPA Commends Trump Administration for Launching Section 301 Investigations Targeting Global Manufacturing Overcapacity and Forced Labor

CPA Commends Trump Administration for Launching Section 301 Investigations Targeting Global Manufacturing Overcapacity, Forced Labor

Section 301 is a powerful tool for addressing foreign policies that distort global markets and disadvantage American producers. When foreign governments explicitly pursue overproduction and then export the resulting surplus into the United States, the effect is to displace domestic output and deter new investment in American manufacturing.